Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Nobukazu Yuki"'
Publikováno v:
Hepatitis Research & Treatment. 2013, p1-6. 6p.
Autor:
Michio Kato, Shinji Matsumoto, Kiyoshi Mochizuki, Kenichi Tadokoro, Nobukazu Yuki, Toshikazu Yamaguchi
Publikováno v:
Journal of Hepatology. 44:302-309
Liver negative-strand hepatitis C virus (HCV) RNA is the most direct indicator of active viral replication but has only been examined in a few semiquantitative studies.Positive- and negative-strand HCV RNA in the right (R) and left (L) liver lobes wa
Publikováno v:
Hepatology Research. 28:73-78
Interferon (IFN) alfa-2a was administered to 23 patients with chronic hepatitis B daily for 4 weeks and the relation between the efficacy of the treatment and changes in total hepatitis B virus (HBV) DNA and precore mutant levels was investigated. At
Autor:
Kenya Iyoda, Keiji Yamamoto, Michio Kato, Norio Hayashi, Eriko Satomi, Hajime Wakeshima, Tomoki Michida, Nobukazu Yuki
Publikováno v:
Kanzo. 45:581-588
HBVキャリアには様々な病態が存在するが, 明瞭なステージ分類が存在せず, 客観的な病態把握が困難である. そこでHBVマーカー, ALT値, 年齢および発癌リスクによるHBVキャリアのステージ分
Autor:
Masao Omura, Nobukazu Yuki, Takayuki Nagaoka, Kiyoshi Mochizuki, Kazumasa Hikiji, Keiji Yamamoto, Michio Kato, Akira Kaneko, Masatoshi Yamashiro
Publikováno v:
Hepatology. 37:1172-1179
The long-term impact of acute self-limited hepatitis B on the liver is unknown. Fourteen patients were recalled at a median of 4.2 years (range, 1.8-9.5 years) after the onset of acute hepatitis B. All showed clinical and serologic recovery with circ
Autor:
Nobukazu Yuki, Yasunori Sugiyasu, Kenya Iyoda, Takayuki Nagaoka, Keiji Yamamoto, Kunimitsu Kawahara, Kazumasa Hikiji, Yoshimi Kakiuchi, Akira Kaneko, Masatoshi Yamashiro, Michio Kato
Publikováno v:
Journal of Medical Virology. 69:41-49
The long-term histological and virological outcomes of spontaneous circulating hepatitis C virus (HCV) clearance were studied in chronic liver disease. Between 1979 and 1984, three patients underwent laparoscopy for chronic non-A, non-B liver disease
Autor:
Keiji Yamamoto, Kenya Iyoda, Masahiro Ikeda, Masato Komori, Yoshimi Kakiuchi, Manabu Masuzawa, Michio Kato, Nobukazu Yuki, Yasunori Sugiyasu, Eriko Fujii, Akira Kaneko, Kazuhei Kurosawa
Publikováno v:
Journal of Clinical Gastroenterology. 31:297-301
Approximately half of all patients with chronic hepatitis C show an initial biochemical response to interferon, but only 15% to 20% of patients achieve a sustained response. We studied the efficacy of retreatment with interferon for patients with chr
Autor:
Yoshiya Nishimura, Akira Kaneko, Michio Kato, Kazuhei Kurosawa, Masahiro Ikeda, Eriko Satomi, Nobukazu Yuki, Keiji Yamamoto, Yasunori Sugiyasu, Masato Komori, Kenya Iyoda, Tomoki Michida
Publikováno v:
Digestive Endoscopy. 12:25-28
Background: Gastric antral vascular ectasia (GAVE), as a cause of upper gastrointestinal bleeding, has been treated surgically, endoscopically and pharmacologically for the past 20 years. Methods: We analyzed the clinical effect of endoscopic treatme
Autor:
Manabu Masuzawa, Nobukazu Yuki, Michio Kato, Michikazu Kono, Akinori Kasahara, Kenya Iyoda, Norio Hayashi, Teruhisa Akeyama
Publikováno v:
Kanzo. 41:323-327
C型慢性肝炎に対する初回インターフェロン治療で再燃を示した42例を対象に10カ月間のIFN再投与を施行し, その有効性と治療効果に影響する因子を検討した. 投与法はrIFNα2a9MUを2週間連日
Autor:
Hisashi Ishida, Masatsugu Hori, Yoshiki Matsushita, Norio Hayashi, Yutaka Sasaki, Manabu Masuzawa, Hiroshi Kishimoto, Michio Kato, Tsutomu Tabata, Nobukazu Yuki, Takashi Inoue
Publikováno v:
Journal of Medical Virology. 59:431-436
A novel hepatitis-associated DNA virus, designated as transfusion-transmitted virus (TTV), was identified recently. We investigated the frequency of TTV viremia in hepatitis C virus (HCV) carriers on maintenance hemodialysis to determine whether TTV